During the past decade, University of Sao Paulo General Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Sao Paulo General Hospital" #1 sponsor was "University of Sao Paulo General Hospital" with 42 trials, followed by "University of Sao Paulo" with 6 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Instituto do Coracao" with 1 trials sponsored and "São Paulo State University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Sao Paulo General Hospital" #1 collaborator was "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 14 trials as a collaborator, "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 3 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Andréa Maria Cordeiro Ventura" with 1 trials as a collaborator and "Coordenação de Aperfeiçoamento de Pessoal de Nível Superior." with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "University of Sao Paulo General Hospital" are "Autoimmune Thyroiditis" (2 trials), "COVID-19" (2 trials), "Mild Cognitive Impairment" (2 trials), "AIDS" (1 trials) and "Acute Kidney Injury" (1 trials). Many other conditions were trialed in "University of Sao Paulo General Hospital" in a lesser frequency.

Most popular intervention types in "University of Sao Paulo General Hospital" are "Drug" (15 trials), "Other" (14 trials), "Device" (11 trials), "Procedure" (11 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Control" (2 trials), "Placebo" (2 trials), "1/4 fluoroscopy dose" (1 trials), "Acceptance and Commitment Therapy for Insomnia" (1 trials) and "Aspiration of the dominant follicle" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Sao Paulo General Hospital" are 44 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 8 active trials in "University of Sao Paulo General Hospital". 1 are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in University of Sao Paulo General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Sao Paulo General Hospital, 3 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 31 trials that are defined as “Not Applicable".